Author:
Birgersson Lina,Borbély Gábor,Caporale Nicolò,Germain Pierre-Luc,Leemans Michelle,Rendel Filip,D’Agostino Giuseppe Alessandro,Bressan Raul Bardini,Cavallo Francesca,Chorev Nadav Even,Kos Vesna Munic,Lazzarin Maddalena,Pollard Steven M.,Sundström Birgitta,Tobon Alejandro Lopez,Trattaro Sebastiano,Zanella Matteo,Bergman Åke,Damdimopoulou Pauliina,Jönsson Maria,Kiess Wieland,Kitraki Efthymia,Kiviranta Hannu,Öberg Mattias,Rantakkoko Panu,Rudén Christina,Söder Olle,Bornehag Carl-Gustaf,Demeneix Barbara,Fini Jean-Baptiste,Gennings Chris,Nånberg Eewa,Rüegg Joëlle,Sturve Joachim,Testa Giuseppe
Abstract
ABSTRACTConvergent evidence associates endocrine disrupting chemicals (EDCs) with major, increasingly-prevalent human disorders. Regulation requires elucidation of EDC-triggered molecular events causally linked to adverse health outcomes, but two factors limit their identification. First, experiments frequently use individual chemicals, whereas real life entails simultaneous exposure to multiple EDCs. Second, population-based and experimental studies are seldom integrated. This drawback was exacerbated until recently by lack of physiopathologically meaningful human experimental systems that link epidemiological data with results from model organisms.We developed a novel approach, integrating epidemiological with experimental evidence. Starting from 1,874 mother-child pairs we identified mixtures of chemicals, measured during early pregnancy, associated with language delay or low-birth weight in offspring. These mixtures were then tested on multiple complementary in vitro and in vivo models. We demonstrate that each EDC mixture, at levels found in pregnant women, disrupts hormone-regulated and disease-relevant gene regulatory networks at both the cellular and organismal scale.
Publisher
Cold Spring Harbor Laboratory
Reference49 articles.
1. Centers for Disease Control and Prevention. Atlanta (GA): US Department of Health and Human Services. National Center for Chronic Disease Prevention and Health Promotion (2014).
2. WHO. State of the science of endocrine disrupting chemicals 2012: an assessment of the state of the science of endocrine disruptors prepared by a group of experts for the United Nations Environment Programme and World Health Organization. Geneva, WHO (2013).
3. Low dose mixture effects of endocrine disrupters and their implications for regulatory thresholds in chemical risk assessment
4. Neuropsychiatric and neurodevelopmental outcome of children at age 6 and 7 years who screened positive for language problems at 30 months
5. Prevalence of diabetes and obesity in association with prematurity and growth restriction;Diabetes Metab. Syndr. Obes.,2017